Many have wanted the data - and the final publication for the Nitazoxanide for Norovirus in Transplants Study is out! Time to stop using nitazoxanide for norovirus - zero impact on virology, no impact on clinical outcomes and clear financial toxicity. pubmed.ncbi.nlm.nih.gov/42177030/

A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell a...

Norovirus (NoV) may cause or contribute to chronic diarrhea among immunocompromised hosts. Neither vaccines nor antiviral therapies are available to prevent or treat NoV. We conducted an NIH-sponsored...

pubmed.ncbi.nlm.nih.gov

ESGICH is trying to learn about what local/regional Immunocompromised Host ID Networks that hold meetings to share challenging cases or other info. If you participate in these or don’t have access to one and would want to - please complete the survey. forms.gle/jTUoweU1ebu8...

ESGICH Local or Regional Immunocompromised ID Networks Survey

Having forums to discuss challenging cases or novel approaches to the diagnosis and treatment of infections in immunocompromised patients are critical. There are a number of local and regional networ...

forms.gle

On behalf of the TID section of TTS, ESGICH and the @thetxidjournal.bsky.social we invite you to: ESGICH – CPC Webinar: Thursday, April 9, 2026, at 14:00 CET

A Neglected Tropical Disease Beyond Endemic Borders: A Case-Based Discussion Registration link: us06web.zoom.us/webinar/regi...

Submit Ideas for Potential ESGICH Sessions at ESCMID Global 2027: If you have ideas for sessions, even if attend the in person meeting, please submit the ideas online . You can submit ideas by close of business April 17 via this link: forms.gle/ecb4ZrJkK9F3... 3/3

ESGICH ESCMID Global 2027 Session Concept Submission Form

Please use this form for ideas for sessions at ESCMID Global 2027. These must be submitted by April 17, 2026 5pm CET so that we can discuss them at our in person/Zoom planning meeting.

forms.gle

Participate in the Session Brainstorming Session: Sunday April 19 at 10:30am – 12:30pm in ICM 2nd Floor, Ostersee Room. A Zoom link will be shared shortly. If you want to participate in this session, please sign up using this link: forms.gle/vNnPYFuifXUH... 2/3

ESGICH Planning Committee for 2027 ESCMID Global

This will be a small working group to help develop proposals for ESGICH to propose for the 2027 ESCMID Global Program. The group will brainstorm in person at ESCMID Global in Munich: Sunday April 1...

forms.gle

ESGICH is seeking help in developing proposals for @escmid.bsky.social Global 2027. We are seeking participation in a brainstorming session in Munich April 19 10:30am - 12:30pm in Ostersee Room, 2nd Floor of the ICM. We are also seeking ideas for sessions. See next tweets w/ details 1/3

ESGICH is seeking help in developing proposals for @escmid.bsky.social Global 2027. We are seeking participation in a brainstorming session in Munich April 19 10:30am - 12:30pm in Ostersee Room, 2nd Floor of the ICM. We are also seeking ideas for sessions. See next tweets w/ details 1/3

3 years ago, I was in the Community of Leaders group and can say it had such a huge impact on how I lead - I recommend this to anyone who wants to be a more engaged and effective leader! Time well spent!

IDSA@idsainfo.bsky.social · 5mo ago

DYK? IDSA's Leadership Institute has TWO pathways: Rising Leaders for early-career ID professionals (online) and Community of Leaders for mid/senior-career pros (hybrid). Both programs run once a year. Get notified when applications open: https://bit.ly/4tNRR3O

First human #H5N1 case of 2026 in #Cambodia: a 30-year-old man from Kampot province. Sequencing, virus isolation & animal investigations ongoing. Dead chicken at home before onset. Patient has since recovered. 🦠💉😷🐓🥼🔬🧪 Sequencing, contact tracing, and poultry investigations ongoing.

Not surprisingly, most adults healthcare-associated respiratory virus infections are immunocompromised and they account for the sickest patients. A key signal to better protect our most vulnerable patients. onlinelibrary.wiley.com/doi/10.1111/...

Hospital‐Acquired Respiratory Viral Infections (HA‐RVIs) Over 10 Years Disproportionally Affect the Immunocompromised

The incidence of HA-Flu/RSV/PIV is associated with patients at high risk of developing RVI complications such as oncology and SCT patients and that most HA cases occur during winter respiratory virus...

onlinelibrary.wiley.com

www.science.org/content/arti...

Bird flu antibodies found in cow in the Netherlands, a first outside of U.S.

Dead cat led to discovery, but officials stress no further spread of H5N1 has been detected

science.org

So happy to see this paper out after a lot of persistence from Shardul Rathod @hannahnam.bsky.social @ucirvine.bsky.social. Over a 10 yr period, 6.6% of Flu cases, 12.2% of RSV cases, and 10.9% of PIV cases were Hosp-Acquired. Most in ICH. onlinelibrary.wiley.com/doi/10.1111/...

Hospital‐Acquired Respiratory Viral Infections (HA‐RVIs) over 10 Years Disproportionally Affect the Immunocompromised

The incidence of HA-Flu/RSV/PIV is associated with patients at high risk of developing RVI complications such as oncology and SCT patients and that most HA cases occur during winter respiratory virus...

onlinelibrary.wiley.com

I had the HUGE honor of being the 40th Forbes Fellow - when I was the previous awardees, I was truly humbled. The ID community is incredible in Melbourne. @monashuniversity.bsky.social @unimelb.bsky.social @thedohertyinst.bsky.social @trubianojason.bsky.social @bradgardiner.bsky.social

Due to the USG Shutdown, I wasn’t able to attend or present @idweek.bsky.social. I was supposed to give the talk on top viral studies that will impact your practice. Here are the papers I was going to highlight: See next posts

Due to the US Government Shutdown, I will not be able to atted @IDWeek.bsky.social #IDWeek2025. I had worked on my 2 invited talks and so will share them. My first talk was going to be about the epidemiology and clinical course of respiratory viral infections in the immunocompromised.

Excited to see the “Advances in Influenza Therapeutics” supplement out in @jidjournal.bsky.social - led by Fred Hayden and Rich Whitley, this supplement reviews what we know about antivirals and how they should be used for influenza. academic.oup.com/jid/issue/23...

Volume 232 Issue Supplement_3 | The Journal of Infectious Diseases | Oxford Academic

An official journal of the Infectious Diseases Society of America. Publishes research results on microbiology, immunology, and epidemiology; pathogenesis, diagnosis, and treatment of infectious diseas...

academic.oup.com

Do you focus on HSCT/Oncology ID? Want to be part of the editorial team of @thetxidjournal.bsky.social? Please apply by October 17 for an open position as outlined in this link!

Transplant Infectious Disease Journal@thetxidjournal.bsky.social · 10mo ago

@thetxidjournal.bsky.social is seeking applications for those interested in joining the editorial team (onlinelibrary.wiley.com/page/journal...) as an Associate Editor. We are specifically seeking someone who has clinical and research experience focused on HSCT/Oncology ID for this position. 1/4

check out our review of donor-derived infections in heart & lung transplant recipients! was a pleasure working with @michaelisonmd.bsky.social on this! #TxID doi.org/10.1016/j.jh...

The ISRV AVG meeting kicked of by Fred Hayden giving the 2nd Roberts/Tisdale lecture on the clinical implications of antiviral resistance.

Excited to have this paper out! Demonstrates that the recipients of lung 🫁 tx for COVID-Associated Lung Injury (CALI) loose humoral protection and have unique cellular immune responses. www.sciencedirect.com/science/arti...

Identification of immune signatures associated with both SARS-CoV-2 infection and lung transplantation

Lung transplantation (lung-tx) offers the last life-saving option for patients with COVID-19-associated lung injury (CALI). We show that the RBD-speci…

sciencedirect.com

AJT’S new ID blog, TxIDExchange, is dedicated to sharing the latest ID updates, research, and guidelines relevant to the transplant community. We’re soliciting blog posts and comments from you and your colleagues and encourage you to participate. ajt-transplant-id-exchange.squarespace.com

Don't miss the new @amjtransplant.bsky.social #TxID blog led by Emily Blumberg ajt-transplant-id-exchange.squarespace.com #wtc2025 @ast-idcop.bsky.social @ast-tyfcop.bsky.social @astinfo.bsky.social

AJT Transplant ID Exchange

ajt-transplant-id-exchange.squarespace.com

Excited to head to San Francisco for #WTC2025 @ast-idcop.bsky.social

Michael Woodward presented on utility of FMT in ICHs - can reduce risk of recurrent C diff and MDRO infections - cost, availability and lack of guidance are limiting application @fredhutch 5th Symposium on ID in ICHs. www.science.org/doi/10.1126/...

Mike Satlin gave an incredible review of MDR-GBR. These challenging bacteria cause freq infections and screening for can inform management of F&N @fredhutch.bsky.social 5th Symposium on ID in ICHs.

Jay Fishman provided the keynote on Xenotransplantation- major progress but many unknowns- thankfully formal clinical trials will help inform optimal approach @fredhutch.bsky.social 5th Symposium on ID in ICHs.

Erika Kampouri provided a masterful review of infections after CAR-T and the impact of CMV and HHV6 in these patients - HHV6 CNS disease rare, CMV needs more data to confirm optimal management. @fredhutch.bsky.social 5th Symposium on ID in ICHs onlinelibrary.wiley.com/doi/10.1111/...

Charles Chiu @UCSF gave an amazing lecture on mNGS in immunocompromised- while helpful, limitations exist and must be recognized to interpret the results.

Amazing talk on aging and infection Maheen Abidi - many questions and need for data to inform management approaches. @fredhutch.bsky.social Symposium of Infections in ICH

Hans Hirsch provided a master class in BKV as the keynote for the 5th @fredhutch.bsky.social Symposium on Infections in ICH. Studies have advanced our understanding of pathogens and management - but many questions remain.